Discontinuation of first-line DMTs among patients with stable MS for at least 5 years may lead to an increased risk for recurrence.

Pfizer's strong Q4 2024 results showcase growth in cancer drugs and Vyndaqel sales. Learn why PFE stock is a top pick for ...

Ospomyv, a biosimilar to Prolia, is indicated for postmenopausal women and men at high risk of fracture, while Xbryk, a ...

President Donald Trump said Tuesday that he will likely impose tariffs of 25% or more on imports of cars, semiconductors and pharmaceutical products. Speaking to reporters at his Mar-a-Lago club in ...

Following an eventful West Coast Swing, the PGA Tour heads to Mexico for the Mexican Open. Here are the latest odds and our ...

On February 13, 2025, the FDA approved Samsung Bioepis Co., Ltd.’s denosumab biosimilars, OSPOMYV™ (denosumab-dssb; 60 mg pre-filled syringe) ...

Aristotle Capital’s Global Equity Composite posted a total return of -7.72% gross of fees (-7.80% net of fees). Click here to ...